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Size at birth and blood pressure 
in young adults: fi ndings from a 
Brazilian birth cohort study
Tamanho ao nascer e pressão arterial 
em adultos jovens: achados de uma 
coorte de nascimentos brasileira
ABSTRACT
OBJECTIVE: To describe the prevalence of borderline blood pressure (BBP) 
and hypertension (HT) among young adults and to assess the association 
between size at birth and BBP/HT.
METHODS: Data were collected from the fi rst Ribeirão Preto Birth Cohort 
Study conducted in the city of Ribeirão Preto, southeastern Brazil, that started 
in 1978-1979. Of the 6,827 singletons born in hospitals, 2,060 were assessed at 
23-25 years of age. Blood samples were collected, an anthropometric assessment 
was performed, and information was obtained regarding occupation, schooling, 
life habits and chronic diseases. Blood pressure (BP) was classifi ed as: 1) BBP: 
systolic BP (SBP) ≥ 130 mm Hg and < 140 mm Hg and/or diastolic BP (DBP) 
≥ 85 mm Hg and < 90 mm Hg; and 2) HT: SBP ≥ 140 mm Hg and/or DBP 
≥ 90 mm Hg. A polytomic logistic regression model was used.
RESULTS: BBP prevalence was 13.5% (males: 23.2%) and HT prevalence 
9.5% (males: 17.7%). BBP was independently associated with male gender 
(relative risk [RR] 8.84; 95%CI 6.09;12.82); birth length ≥ 50 cm (RR 1.97; 
1.04;3.73); body mass index (BMI) ≥ 30 kg/m2 (RR 3.23; 2.02;5.15); and high 
waist circumference (RR 1.61; 1.13;2.29), while HT was associated with male 
gender (RR 15.18; 8.92;25.81); BMI ≥ 30 kg/m2 (RR 3.68; 2.23;6.06); high 
waist circumference (RR 2.68; 1.77;4.05); and elevated blood glucose (RR 
2.55; 1.27; 5.10), but not with birth length.
CONCLUSIONS: The prevalence of BBP and HT among young adults of this 
cohort was higher in males than females. Greater birth length was associated 
with BBP, but not with HT, whereas birth weight was not associated with 
either BBP or HT. Adult risk factors explained most of the increase in the 
levels of BBP and HT.
DESCRIPTORS: Borderline blood pressure, hypertension, birth weight, 
birth length, young adults, cohort studies, obesity, abdominal obesity, 
high blood glucose.
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Essential hypertension is an important risk factor for 
morbidity and mortality from coronary heart disease, 
stroke, and renal disease.26 Although clinical manifes-
tations of hypertension (HT) do not generally emerge 
until middle age, the pathophysiologic precursors of 
adult HT are thought to originate very early in life even 
during fetal development.
Fetal growth disorders are associated with chronic non-
communicable diseases in adulthood, among them HT, 
according to the fetal origins of adult disease hypoth-
esis.6 However, it is not clear whether early life factors 
such as weight and length at birth are also associated 
with borderline blood pressure (BBP).
Prospective studies show that HT is preceded by a 
prehypertension stage characterized by abnormalities 
considered as potential metabolic precursors of HT.14,24
The course of concurrent development of adverse 
blood pressure (BP) levels and other risk factors for the 
metabolic syndrome during childhood, adolescence, and 
RESUMO
OBJETIVO: Descrever a prevalência de pressão arterial limítrofe (PAL) e 
hipertensão (HT) entre adultos jovens e avaliar a associação entre tamanho 
ao nascer e PAL/HT.
MÉTODOS: Dados foram coletados do primeiro estudo brasileiro de coorte 
de nascimentos em Ribeirão Preto (sudeste do Brasil), iniciado em 1978/79. 
De 6.827 recém-nascidos de parto único hospitalar, 2.060 foram avaliados aos 
23/25 anos. Foram realizadas coleta de sangue, avaliação antropométrica e 
obtidas informações sobre ocupação, escolaridade, hábitos de vida e doenças 
crônicas. Pressão arterial (PA) foi classifi cada em: 1) PAL: PA sistólica (PAS) 
≥ 130 e < 140 mm Hg e/ou PA diastólica (PAD) ≥ 85 e < 90 mmHg; 2) HT: 
PAS ≥ 140 e/ou PAD ≥ 90 mm Hg. Foi aplicado modelo de regressão logística 
politômica.
RESULTADOS: A prevalência de PAL foi de 13,5% (homens 23,2%) e a de 
HT, 9,5% (homens 17,7%). PAL foi independentemente associada com sexo 
masculino (RR 8,84; IC95%: 6,09;12,82), comprimento ao nascer ≥ 50 cm 
(RR 1,97; 1,04; 3,73), índice de massa corporal (IMC) ≥ 30 kg/m2 (RR 3,23; 
2,02; 5,15) e circunferência de cintura alterada (RR 1,61; 1,13;2,29), enquanto 
HT associou-se com sexo masculino (RR 15,18; 8,92;25,81), IMC ≥ 30 kg/m2 
(RR 3,68; 2,23;6,06), circunferência de cintura alterada (RR 2,68; 1,77;4,05) e 
glicemia elevada (RR 2,55; 1,27;5,10), mas não com comprimento ao nascer.
CONCLUSÕES: As prevalências de PAL e HT entre os adultos jovens dessa 
coorte foram maiores em homens que em mulheres. Maior comprimento ao 
nascer foi associado com PAL, mas não com HT, enquanto peso ao nascer 
não foi associado com PAL ou HT. Fatores de risco do adulto explicaram a 
maioria dos aumentos de PAL ou HT.
DESCRITORES: Pressão arterial limítrofe, hipertensão, peso ao nascer, 
comprimento ao nascer, adultos jovens, estudos de coortes, obesidade, 
obesidade abdominal, glicemia elevada.
INTRODUCTION
young adulthood still needs elucidation. BBP, a new risk 
category for Latin American and European countries, 
includes a population at high risk of developing HT and 
in which lifestyle modifi cations are needed. This might 
be useful not only in assessing future risk of hyperten-
sion but also in prevention and intervention algorithms.11
This study aimed to describe the prevalence of BBP and 
HT among young adults and to assess the association 
between size at birth and BBP/HT.
METHODS
Study carried out with data from the fi rst Ribeirão Preto 
Birth Cohort Study conducted in the city of Ribeirão 
Preto, southeastern Brazil, that started in 1978-1979. 
Data were obtained at birth and at young adult age 
(23 to 25 years). There were recruited 9,067 liveborn 
infants delivered at the city’s eight maternity hospitals 
from June 1st, 1978 to May 31, 1979 (98% of all live 
births). Infants whose families did not reside in the 
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city (2,094) and twins (146) were excluded from the 
study, remaining 6,827 live births.9 Information about 
mother’s age, schooling and smoking was obtained 
through interviews with the mothers after delivery and 
review of medical records at the maternity hospitals. 
Birth weight and length were measured within 30 
minutes of birth by trained personnel with appropriate 
devices that were donated by the research team to all 
hospitals. The infants were weighed naked on scales 
that were calibrated on a weekly basis with 10-g preci-
sion (Filizola, São Paulo, Brazil). Two trained staff 
members measured length at birth with the infants lying 
in the supine position on a neonatometer with a fi xed 
vertical headpiece and a smooth sliding vertical foot-
piece. Measurements were taken to the nearest 0.5 cm.
From the original cohort, 30% of subjects were selected 
to participate in the adult follow-up (between 2002 
and 2004). This sample size was enough to test the 
study hypothesis. Of 6,827 singleton liveborns, 343 
subjects were found to be deceased and 819 could not 
be traced, leaving 5,665 singletons. Subjects were clas-
sifi ed according to the income of the head of the family 
(geoeconomic classifi cation) to ensure a representative 
sample of socioeconomic groups. One in every three 
subjects from the same geographic area was invited to 
undergo medical examination. The fi rst of every three 
names was selected from a list sorted by birth date in 
each geographic area, and if unavailable the next name 
down was selected. Losses to follow-up (n = 705) 
occurred because of refusal to participate, imprisonment, 
death after 20 years of age, or failure to show up for the 
interview. Losses were replaced using the same sampling 
method, resulting in 2,063 young adults (Figure).5 Data 
were obtained by structured questionnaires, physical 
examination, and blood collection. Anthropometric 
measurements (weight, height, and waist circumfer-
ence) were taken according to standardized techniques 
with subjects barefoot and wearing light clothing. The 
instruments used were a precision scale periodically cali-
brated, anthropometers for standing and sitting measure-
ments, a non-extensible metric tape and a caliper. Blood 
pressure was measured three times using a digital sphyg-
momanometer with a cuff of the same size which was 
adjusted to the arm circumference. The measurements 
were taken by the same examiner at 15-min intervals, 
with the subject resting in the sitting position with the 
left arm at the height of his/her heart. The mean of the 
last two measurements was then calculated.
Three of 2,063 subjects were excluded because of 
technical diffi culties in recording BP (extreme obesity), 
totaling 2,060 young adults. A sample size of 1,291 
was needed to test the study hypothesis assuming the 
event had a 10% prevalence with a 5% probability of 
type I error and 1% precision. Details regarding the 
methodology are available elsewhere.5,9
Blood pressure was the primary outcome measure and 
was classifi ed into three groups: 1) normal blood pressure 
(NT): systolic BP (SBP) < 130 mm Hg and/or diastolic 
BP (DBP) < 85 mm Hg; 2) borderline blood pressure 
(BBP): SBP 130 mm Hg to 139 mm Hg and/or DBP 
85 mm Hg to 89 mm Hg; 3) hypertension (HT): SBP 
≥ 140 mm Hg and/or DBP ≥ 90 mm Hg according to 
Argentinean, Brazilian, and European guidelines.12,23,25
Sociodemographic characteristics were evaluated at 
birth: mother’s age (years), maternal schooling (years), 
occupation of the head of the family according to the 
International Standard Classifi cation of Occupation21 
and maternal smoking (no smoking; 1-10; > 10 ciga-
rettes). Gender, gestational age, birth weight (BW), 
length, ponderal index (PI, kg/m3), and adverse peri-
natal outcomes (low birth weight [LBW, < 2,500 g], 
Figure. Subjects from the 1978-1979 Ribeirão Preto Birth 
Cohort Study evaluated at the age of 23-25 years. Ribeirão 
Preto, Southeastern Brazil, 1978-1979.
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small for gestational age [SGA, BW lower than the 10th 
percentile27], preterm birth [< 37 completed weeks]) 
were presented.
Adulthood sociodemographic characteristics evalu-
ated were: occupation of the head of the family; 
smoking habit (no smoking; 1-10; > 10 cigarettes); 
physical activity (active, suffi ciently active, and inac-
tive according to the International Physical Activity 
Questionnaire scoring protocol);a alcohol consumption 
(g/day; high > 31 g/day; low ≤ 31 g/day).4
The recommendation of the World Health Organization 
(WHO) of a daily intake of < 5.0 g of salt (2,000 mg 
of sodium) was adopted to defi ne the cut-off of high 
sodium intake in mg/day.28
Obesity in adulthood was defi ned as BMI ≥ 30 kg/m2. 
Abdominal obesity was based on the waist circumfer-
ence cut-offs proposed for the metabolic syndrome 
classifi cation by the International Diabetes Federation.2 
Fasting blood glucose was determined by the GOD/
PAP human diagnostic colorimetric enzymatic method 
(Chronolab AG, Zug, Switzerland) and was considered 
high when ≥ 100 mg/dL.2 Total cholesterol, HDL 
cholesterol, and triglycerides were determined by an 
enzymatic colorimetric method using the Dade Behring 
XPand device (Dade Behring, Liederbach, Germany) 
and reagents of Dade Behring Dimension clinical chem-
istry. Insulin resistance was estimated by a so-called 
surrogate marker,18 the triglyceride-to-high density 
lipoprotein (TG/HDL) ratio, which has been proposed 
as one of the most accurate surrogate markers; optimal 
cut-off was 2.90 or less.
All variables are presented as proportions (n, %) and 
the three levels of blood pressure were compared by 
the chi-square test.
A univariate risk analysis between BBP/HT and covari-
ates was performed. The variables with a p < 0.05 were 
included in a polytomic logistic regression analysis to 
evaluate the risk of both BBP and HT; SBP < 130 mm 
Hg and/or DBP < 85 mm Hg were the reference values. 
To be consistent with the literature, we opted to keep 
birth weight as a covariate in the regression models.
Three models were constructed: the fi rst one (1) was 
adjusted for sociodemographic and clinical conditions 
at birth; the second one (2) include sociodemographic 
and clinical conditions and biochemical markers during 
young adulthood; and the third one (3) was adjusted for 
variables included in previous models. Interaction terms 
were tested for signifi cance. The models were tested 
for collinearity using the ‘‘vif’’ command of the Stata 
software, version 9.0 (College Station, Texas, USA). 
Statistically signifi cant difference was set at p < 0.05.
The study was approved by the Research Ethics 
Committee of Ribeirão Preto University Hospital, 
Faculdade de Medicina de Ribeirão Preto, 
Universidade de São Paulo (HCFMRP-USP). 
Confi dentiality was ensured.
RESULTS
The study sample at birth and at 23-25 years of age 
was comparable with the original population regarding 
birth variables: birth weight (p = 0.618) and length 
(p = 0.507), SGA (p = 0.513), and maternal age at 
delivery (p = 0.065). There were slight differences 
between those followed up and those who did not 
participate. There was a predominance of women 
(p = 0.004), preterms (p = 0.037), belonging to families 
with more qualifi ed occupations (p < 0.001), mothers 
with fi ve years or more of schooling (p < 0.001), 
married mothers (p < 0.001), and who did not smoke 
at the time of delivery (p < 0.001) (data not shown).
Males accounted for 48.2% (95%CI 46.1;50.4) of the 
sample. The prevalence of BBP was 13.5% (n = 279, 
95%CI 12.1;15.0) and HT 9.5% (n = 196, 95%CI 
8.3;10.8). BBP and HT were signifi cantly higher in 
males than females (23.2% vs. 4.5% for BBP and 17.7% 
vs. 1.9% for HT, respectively, p< 0.001).
BBP and HT were positively associated with birth 
length but not with birth weight. Subjects with a birth 
length of 50 cm or more had signifi cantly greater 
proportions of BBP and HT. Ponderal index was not 
associated with blood pressure.
No differences were observed for maternal characteris-
tics at birth, preterm, LBW or BW for gestational age 
according to blood pressure levels (Table 1).
Occupation of the head of the family and smoking 
were not signifi cantly associated with BP levels among 
young adults. A physically active life, high alcohol 
consumption, and elevated sodium intake per day were 
signifi cantly higher in BBP/HT. Subjects with BBP 
and HT tended to have high BMI (≥ 30 kg/m2) and 
abdominal obesity. Similar fi ndings were found for high 
fasting blood glucose and triglyceride/HDL cholesterol 
ratio > 2.90 (Table 2).
Male gender showed the strongest association with 
BP levels in univariate analyses at birth; there was an 
eight-fold increase in the effect estimate (crude rela-
tive risk [RR] 8.18, 95%CI 5.89;11.34) for BBP and 
a fourteen-fold increase for HT (RR 14.96, 95%CI 
9.31;24.02) in males compared to females (p < 0.001). 
Birth length > 50 cm showed a signifi cantly increase 
only for the risk of BBP (RR 1.92, 95%CI 1.20;3.05, 
a International Physical Activity Questionnaire. Guidelines for data processing and analysis of the International Physical Activity Questionnaire 
(IPAQ): Short and Long Forms. Stockholm; 2005 [cited 2006 Mar 3]. Available from: http://www.ipaq.ki.se/scoring.pdf 
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Table 1. Sociodemographic and clinical characteristics at birth according to blood pressure levels. Ribeirão Preto Birth Cohort 
Study, Ribeirão Preto, Southeastern Brazil, 1978-1979.a
Variable
Normal blood 
pressure 
(n = 1,585)
BBP
(n = 279)
HT
(n = 196)
Total
(n = 2,060)
p-value*
Gender <0.001
Female 998 (93.62) 48 (4.5)   20 (1.88) 1,066 (100)
Male 587 (59.05) 231 (23.24) 176 (17.71)    994 (100)
Maternal age (years) 0.141
< 20 208 (81.89) 27 (10.63) 19 (7.48) 254 (100)
20 to 34 1.246 (76.77) 223 (13.74) 154 (9.49) 1,623 (100)
 35 122 (71.25) 27 (15.79) 22 (12.87)  171 (100)
Maternal schooling (years) 0.818
Up to 8 1,146 (77.75) 195 (13.23) 133 (9.02) 1,474 (100)
9 to 11 249 (75.23) 48 (14.50)   34 (10.27)    331 (100)
12 or more 162 (75.35) 30 (13.95) 23 (10.70) 215 (100)
Occupation of the head of the family 0.377
Non-manual 250 (73.96) 46 (13.61) 42 (12.43) 338 (100)
Manual-skilled 983 (77.77) 170 (13.45) 111 (8.78)  1,264 (100)
Manual unskilled 306 (76.88) 54 (13.57) 38 (9.55) 398 (100)
Maternal smoking 0.478
No smoking 1,228 (77.09) 208 (13.06) 157 (9.86) 1,593 (100)
1 to 10 cigarettes   243 (78.39)  43 (13.87)  24 (7.74)    310 (100)
+ 10 cigarettes  76 (72.38) 19 (18.10)   10 (9.52)  105 (100)
Preterm 0.262
No 1,481 (77.26) 259 (13.51) 177 (9.23) 1,917 (100)
Yes 104 (72.73) 20 (13.99) 19 (13.29)  143 (100)
LBW 0.838
No 1,483 (76.80) 263 (13.62) 185 (9.58) 1,931 (100)
Yes 102 (79.07) 16 (12.40) 11 (8.53)  129 (100)
Birth weight for gestational age 0.366
AGA 1,340 (77.23) 233 (13.43) 162 (9.34) 1,735 (100)
SGA  158 (78.61) 23 (11.44)   20 (9.95)   201 (100)
LGA 87 (70.16) 23 (18.55) 14 (11.29)  124 (100)
Birth length (cm) <0.001
< 47 185 (81.86) 23 (10.18) 18 (7.96) 226 (100)
47 to 49.9 695 (80.25) 89 (10.28) 82 (9.47) 866 (100)
 50 695 (72.62) 166 (17.35) 96 (10.03) 957 (100)
Birth weight (g) 0.695
 3,000 1,158 (76.18) 215 (14.14) 147 (9.67) 1,520 (100)
2,500 to 2,999 325 (79.08)  48  (11.68) 38  (9.25) 411 (100)
< 2,500 102 (79.07) 16 (12.40) 11 (8.53) 129 (100)
PI (kg/m3) 0.053
> 3.0 220 (81.48) 31 (11.48) 19 (7.04) 270 (100)
> 2.5 a 3.0 1,075 (77.39) 182 (13.10) 132 (9.50) 1,389 (100)
 2.5 280 (71.79) 65 (16.67) 45 (11.54) 390 (100)
a Values are numbers (percentage).
* p-values are for the chi-square test
BBP: bordeline blood pressure; HT: hypertension; LBW: low birth weight; AGA: adequate for gestational age; SGA: small for 
gestational age; LGA: large for gestational age (greater than the 90th percentile)25; PI: ponderal index
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p = 0.006). BW had no effect on blood pressure either 
BBP or HT, whereas a signifi cant association between 
ponderal index < 2.5 kg/m3 and blood pressure was seen 
(RR 1.64, 95%CI 1.03;2.61 and 1.86, 95%CI 1.05;3.27 
for BBP and HT, respectively).
The following conditions showed signifi cantly high 
RR for both BBP and HT, being higher for the latter 
in young adults: high alcohol consumption (RR 2.09, 
95%CI 1.44;3.04 and 3.83, 95%CI 2.46;5.98 for BBP 
and HT, respectively); sodium intake > 2,000 mg/day 
(RR 1.39, 95%CI 1.06;1.82 and 1.65, 95%CI 1.20;2.28 
for BBP and HT, respectively); BMI ≥ 30 kg/m2 (RR 
3.38, 95%CI 2.40;4.74 and 5.62, 95%CI 3.94;8.01 for 
BBP and HT, respectively); abdominal obesity (RR 
2.49, 95%CI 1.92;3.23 and 4.47, 95%CI 3.28;6.09 for 
BBP and HT); high fasting blood glucose (RR 2.69, 
95%CI 1.49;4.85 and 4.49, 95%CI 2.52;7.98 for BBP 
and HT); and elevated triglyceride/HDL cholesterol 
Table 2. Sociodemographic, clinical and biochemical characteristics in young adulthood according to blood pressure levels. 
Ribeirão Preto Birth Cohort Study, Ribeirão Preto, Southeastern Brazil, 1978-1979.a
Normal blood 
pressure (n = 1,585)
BBP
(n = 279)
HT
(n = 196)
Total
(n = 2,060)
P*
Occupation of the head of the family 0.400
Non-manual 518 (74.64) 106 (15.27) 70 (10.09) 694 (100)
Manual skilled 450 (78.67) 67 (11.71) 55 (9.62) 572 (100)
Semi-skilled manual 343 (79.21) 57 (13.16) 33 (7.62) 433 (100)
Unskilled manual 270 (75.84) 49 (13.76) 37 (10.39) 356 (100)
Smoking habit 0.257
No smoking 1,320 (77.37) 231 (13.54) 155 (9.09) 1,706 (100)
1 to 10 cigarettes 164 (76.64) 30 (14.02) 20 (9.35) 214 (100)
>10 cigarettes 101 (72.14) 18 (12.86) 21 (15.00) 140 (100)
Physical activity 0.002
Sedentary 818 (80.12) 117 (11.46) 86 (8.42) 1,021 (100)
Suffi ciently active 304 (77.16) 54 (13.71) 36 (9.14) 394 (100)
Active 457 (71.52) 108 (16.90) 74 (11.58) 639 (100)
Alcohol consumption < 0.001
None 469 (83.45) 61 (10.85) 32 (5.69) 562 (100)
Low ( 31 g/day) 834 (78.09) 142 (13.30) 92 (8.61) 1,068 (100)
High (> 31 g/day) 271 (65.14) 74 (17.79) 71 (17.07) 416 (100)
Sodium intake < 2,000 mg/day < 0.001
Yes 651 (81.17) 93 (11.60) 58 (7.23) 802 (100)
No 934 (74.24) 186 (14.79) 138 (10.97) 1,258 (100)
BMI  30 kg/m2 < 0.001
No 1,461 (80.76) 216 (11.94) 132 (7.30) 1,809 (100)
Yes 122 (49.80) 61 (24.90) 62 (25.31) 245 (100)
Abdominal obesity < 0.001
No 1,174 (83.92) 149 (10.65) 76 (5.46) 1,399 (100)
Yes 411 (62.27) 130 (19.70) 119 (18.03) 660 (100)
High fasting glycemia < 0.001
No 1,531 (77.83) 261 (13.27) 175 (8.90) 1,967 (100)
Yes 37 (50.68) 17 (23.29) 19 (26.03) 73 (100)
Triglyceride/HDL cholesterol ratio < 0.001
Normal ( 2.90) 1,346 (81.58) 189 (11.45) 115 (6.97) 1,650 (100)
Altered (> 2.90) 221 (57.55) 86 (22.40) 77 (20.05) 384 (100)
a Values are numbers (percentage)
* p-values are for the chi-squared test
BBP: bordeline blood pressure; HT: hypertension; BMI: body mass index; HDL: high density lipoprotein
Physical activity: Classifi cation based on the International Physical Activity Questionnaire scoring protocol; Abdominal obesity: 
Classifi cation based on the International Diabetes Federation (waist circumference altered if  90 cm for male and  80 cm for 
female)2; High fasting glycemia = Glycemia ≥ 100 mg/dl2
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ratio (RR 2.77, 95%CI 2.06;3.71 and 4.07, 95%CI 
2.95;5.62 for BBP and HT, respectively). Smoking was 
only associated with HT (RR 1.77, 95%CI 1.07;2.91) 
(data not shown).
In the model 1 (birth) of the polytomic logistic regres-
sion analysis, the magnitude of the association of 
male gender with BBP/HT and birth length with BBP 
persisted after adjustment. In the model 2 (adulthood), 
the risk for BBP increased in males. The positive 
associations between alcohol consumption, sodium 
intake ≥ 2,000 mg/day, smoking, and triglyceride/HDL 
cholesterol ratio were no longer signifi cant, whereas 
additional adjustment removed part of the effect of BMI 
≥ 30 kg/m2 and central obesity on the risk of BBP and 
HT. Similarly, the positive association between high 
fasting blood glucose and HT was reduced but remained 
signifi cantly associated, while for BBP it was reduced 
and was no longer signifi cant after adjustment.
The model 3 shows the combined effect of birth plus 
adulthood variables. For both BBP and HT, the asso-
ciations were mostly consistent with those observed in 
previous models for male gender, BMI ≥ 30 kg/m2 and 
central obesity. Birth length ≥ 50 cm remained associ-
ated with BBP, while high fasting blood glucose was 
only associated with HT. BW was not associated with 
BBP or HT. The replacement of BW and birth length by 
PI was found to have an inverse association with BBP 
(adjusted RR [adjRR] 1.91, 95%CI 1.14;3.20) and HT 
(adjRR 2.29, 95%CI 1.17; 4.4) (Table 3).
There was no evidence of collinearity in the models 
(Table 3). Interaction terms were tested, but none was 
signifi cant at the 0.05 level.
DISCUSSION
One of a few studies conducted in Brazil and Latin 
American middle-income countries has investigated 
the suggested association between weight and size at 
birth and BBP/HT at 23-25 years of age in a popula-
tion-based sample. Among indicators of size at birth, 
only birth length was independently associated with 
BBP at young adulthood. When BBP was replaced by 
prehypertension (SBP 120 mm Hg to 139 mm Hg or 
DBP 80 mm Hg to 89 mm Hg according to the Seventh 
Report of the Joint National Committee on Prevention, 
Detection, Evaluation, and Treatment of High Blood 
Pressure [JNC 7])10 in the model 3, birth length showed 
a signifi cant positive association with BBP but to a 
lesser extent (RR 1.079, 95%CI 1.002;1.162) while BW 
was not associated with either prehypertension or HT.
Consistent with the Barker hypothesis, low birth 
weight is related to higher blood pressure later in life 
in prospective cohort studies. However, other studies 
have not been able to support this association.13,20
The prevalence of HT between 18 and 39 years of 
age was 7.2% in The National Health and Nutrition 
Examination Survey (NHANES) III,15 a proportion that 
is close to that seen in our study (9.5%).
The higher prevalence of HT among men compared to 
women is noteworthy but at a lesser rate compared with 
similar studies.22,8 This may be attributable to a protec-
tive effect of estrogen,19 higher smoking rates among 
men (most of the female subjects were non-smokers), 
higher male height (1.76; standard deviation [SD] 6.48 
m for men vs. 1.62; SD 6.45 m for women, p < 0.001), 
elevated sodium intake ≥ 2,000 mg/day (70 vs. 52%, 
p < 0.001) and abnormal triglyceride/HDL cholesterol 
ratio (27% vs. 11%, p < 0.001) in males compared to 
females (data not shown).
There was a lower risk of central obesity (RR 0.78 
[95%CI 0.69;0.89], p < 0.001) and biochemical markers 
among women compared to men (data not shown). 
Increases in body fat may have different effects in 
women than men, and that a greater degree of adiposity 
must be achieved in women to obtain a signifi cant rise 
in blood pressure and an increase in a lipid risk profi le 
comparable with that of men.
Birth length was positively associated with BBP at 
the age of 23-25 years. The association between birth 
length and blood pressure is controversial. Studies 
from high-income countries, where intrauterine growth 
restriction is rare, have either failed to report an asso-
ciation or found inverse associations.3,17 On the other 
hand, studies from low- and middle-income settings 
have reported positive associations in accordance with 
the present fi ndings and a previous Brazilian study.20 
This is in agreement with a recent systematic review 
which showed that the association between birth size 
and later blood pressure varies according to the level of 
economic development of the country of birth.1
The biological mechanisms by which birth length may 
infl uence blood pressure are not yet clear. High blood 
pressure seen in individuals with higher birth length 
could be associated to greater height in adulthood.
This was confi rmed in a subsequent analysis in which 
height above the mean of this population (169.0 cm, SD 
9.3 cm) was statistically associated with an increase in 
the risk of either BBP (OR 6.01, 95%CI 4.37;8.27, p < 
0.001) or HT (OR 6.84, 95%CI 4.63;10.14, p < 0.001) 
compared with those at or below 169.0 cm (data not 
shown). 
Further studies are needed to confi rm this association 
and to clarify potential biological mechanisms.
Subjects with BBP and hypertension showed as young 
adults an increased prevalence of cardiovascular risk 
factors for the metabolic syndrome, such as measures 
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Table 3. Risk of borderline blood pressure and hypertension in young adults, adjusted by socio-demographic characteristics, 
clinical conditions and biochemical markers by polytomic logistic regression analysis in three models. Ribeirão Preto Birth 
Cohort Study, Ribeirão Preto, Southeastern Brazil, 1978-1979.
Model 1 – birtha Model 2 – adulthooda Model 3 – birth and adulthooda
BBP HT BBP HT BBP HT
RR (95%CI) RR (95%CI) RR (95%CI) RR (95%CI) RR (95%CI) RR (95%CI)
Sex
Female 1 1 1 1 1 1
Male
7.64 
(5.49;10.65)
14.97 
(9.28;24.15)
9.21 
(6.38;13.29)
15.05 
(8.89;25.49)
8.84 
(6.09;12.82)
15.18 
(8.92;25.81)
Length (cm)
< 47 1 1 1 1
47 to 49.9 1.28 (0.72;2.27) 1.37 (0.73;2.56) 1.22 (0.67;2.20) 1.25 (0.63;2.47)
 50 2.02 (1.09;3.75) 1.21 (0.61;2.39) 1.97 (1.04;3.73) 1.06 (0.51;2.22)
Birth weight (g) 
 3,000 1 1 1 1
2,500 to 
2,999
1.29 (0.85;1.97) 1.07 (0.67;1.70) 1.49 (0.96;2.31) 1.20 (0.72;1.98)
< 2,500 1.44 (0.70;2.96) 0.92 (0.40;2.13) 1.63 (0.77;3.48) 0.88 (0.35;2.23)
Alcohol consumption
None 1 1 1 1
Low 1.18 (0.83;1.69) 1.29 (0.81;2.05) 1.17 (0.82;1.68) 1.29 (0.81;2.06)
High 1.07 (0.70;1.64) 1.62 (0.97;2.70) 1.05 (0.68;1.62) 1.62 (0.97;2.71)
Sodium intake < 2,000 mg/day 
Yes 1 1 1 1
No 0.97 (0.72;1.31) 1.04 (0.72;1.50) 0.97 (0.72;1.32) 1.04 (0.72;1.51)
Smoking habit
No smoking 1 1 1 1
1 to 10 
cigarettes 
0.88 (0.55;1.39) 0.77 (0.44;1.35) 0.85 (0.54;1.36) 0.77 (0.44;1.35)
> 10 
cigarettes 
0.61 (0.34;1.09) 0.90 (0.50;1.62) 0.59 (0.33;1.07) 0.90 (0.50;1.63)
BMI  30 kg/m2 
No 1 1 1 1
Yes 3.16 (1.98;5.03) 3.78 (2.30;6.22) 3.23 (2.02;5.15) 3.68 (2.23;6.06)
Abdominal obesity
No 1 1 1 1
Yes 1.62 (1.14;2.30) 2.58 (1.71;3.88) 1.61 (1.13;2.29) 2.68 (1.77;4.05)
High fasting glycemia
No 1 1 1 1
Yes 1.88 (0.98;3.62) 2.63 (1.32;5.23) 1.85 (0.95;3.59) 2.55 (1.27;5.10)
Triglyceride/HDL cholesterol ratio
Normal 
( 2.90) 1 1 1 1
Altered 
(> 2.90)
1.33 (0.94;1.88) 1.37 (0.92;2.04) 1.30 (0.91;1.84) 1.37 (0.92;2.05)
a Normotension as reference value. All models were adjusted for gestational age
BBP: bordeline blood pressure; HT: hypertension; Physical activity: Classifi cation based on the International Physical Activity 
Questionnaire scoring protocol; Alcohol consumption = low:  31 g/day, high: > 31 g/day; Abdominal obesity: Classifi cation 
based on the International Diabetes Federation (waist circumference altered if  90 cm for male and  80 cm for female)2; High 
fasting glycemia = Glycemia ≥ 100 mg/dl2
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of generalized and visceral obesity, adverse glucose 
homeostasis, and dyslipidemia (Table 2).
Near fi fty percent of these young adults lead a sedentary 
life, which could contribute to higher adiposity and 
impaired cardiovascular health later in life, in accor-
dance with similar studies.13
Our study agrees with Bergvall et al7 fi ndings that the 
association of size at birth and blood pressure appears 
not to be confounded by socioeconomic or family effects.
Subjects with hypertension during young adulthood 
showed high alcohol consumption, sodium intake 
≥ 2,000 mg/day, and components of the metabolic 
syndrome (Tables 2-3). These results are consistent 
with the tracking concept (persistence) that risk factors 
remain relatively constant over time. Persistence of 
high blood pressure over time has been demonstrated 
in both pediatric and adult populations. This is an 
important public health issue because of the morbidity 
and mortality related to HT. Monitoring of BP in these 
individuals is recommended.
Some of the mechanisms underlying the associations in 
this study are unclear. Nevertheless, several recognized 
mechanisms could be postulated such as obesity, hyper-
insulinemia/insulin resistance, high sodium intake, and 
infl ammatory markers.11
This is the fi rst study that included BBP, a new category 
of blood pressure classifi cation in Latin American 
countries. The sample followed up from birth to young 
adulthood showed better sociodemographic conditions 
than the original population.
The results of the present study expand a limited body of 
evidence supporting the hypothesis that BBP increases 
the risk of progression to full-blown hypertension in 
young adults.
To the extent that unmeasured risk factors present at 
baseline may be positively correlated with BBP, there 
is a chance that BBP was overestimated. Previous 
observational studies10,25 have reported that the average 
BP in the second visit may be lower than in the initial 
visit due to regression to the mean or the familiariza-
tion of the participants to the clinic setting (white coat 
effect). Consequently, the prevalence of BBP/HT may 
be overestimated.
Our control variables have other shortcomings mainly 
because this study started collecting data more than 30 
years ago when risk factors and levels of risk factors 
were less well established. Misreporting of alcohol 
consumption may have occurred.
The validity of associations between birth weight and 
health in later life might be due in part to inappro-
priate statistical adjustment for variables on the causal 
pathway which creates an artifactual statistical effect, 
known as the reversal paradox.16
The data obtained for this large community-based 
birth cohort support the hypothesis that birth length 
is positively and independently related to blood pres-
sure in early adulthood but do not support an inverse 
association between birth weight and blood pressure. 
Adult risk factors explained most of the increase in the 
levels of BBP and HT.
Moreover, the simultaneous inclusion of current 
BMI with weight and length at birth in the regression 
model (indicating an effect of postnatal growth) did 
not substantially change the effect on the risk of BBP.
Young adults with either BBP or HT showed excess 
adiposity. These results, when analyzed in the context of 
the upward secular trends in adiposity and blood pres-
sure in Brazilian youth, underscore the importance of 
controlling excess adiposity early in life in the general 
population.
Investigation of causative and synergistic interactions of 
high blood pressure and other cardiovascular risk factors 
and of precise physiologic mechanisms associated with 
early onset of high blood pressure is warranted.
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